Long-term clinical outcomes of patients with COVID-19 and chronic liver disease: US multicenter COLD study. Academic Article uri icon

Overview

abstract

  • BACKGROUND: COVID-19 is associated with higher morbidity and mortality in patients with chronic liver diseases (CLDs). However, our understanding of the long-term outcomes of COVID-19 in patients with CLD is limited. METHODS: We conducted a multicenter, observational cohort study of adult patients with CLD who were diagnosed with COVID-19 before May 30, 2020, to determine long-term clinical outcomes. We used a control group of patients with CLD confirmed negative for COVID-19. RESULTS: We followed 666 patients with CLD (median age 58 years, 52.8% male) for a median of 384 (interquartile range: 31-462) days. The long-term mortality was 8.1%; with 3.6% experiencing delayed COVID-19-related mortality. Compared to a propensity-matched control group of patients with CLD without COVID-19 (n=1332), patients with CLD with COVID-19 had worse long-term survival [p<0.001; hazards ratio (HR): 1.69; 95% CI: 1.19-2.41] and higher rate of hospitalization (p<0.001, HR: 2.00, 1.62-2.48) over a 1-year follow-up period. Overall, 29.9% of patients reported symptoms of long-COVID-19. On multivariable analysis, female sex (p=0.05, HR: 2.45, 1.01-2.11), Hispanic ethnicity (p=0.003, HR: 1.94, 1.26-2.99), and severe COVID-19 requiring mechanical ventilation (p=0.028, HR: 1.74, 1.06-2.86) predicted long-COVID-19. In survivors, liver-related laboratory parameters showed significant improvement after COVID-19 resolution. COVID-19 vaccine status was available for 72% (n=470) of patients with CLD and history of COVID-19, of whom, 70% (n=326) had received the COVID-19 vaccine. CONCLUSIONS: Our large, longitudinal, multicenter study demonstrates a high burden of long-term mortality and morbidity in patients with CLD and COVID-19. Symptoms consistent with long-COVID-19 were present in 30% of patients with CLD. These results illustrate the prolonged implications of COVID-19 both for recovering patients and for health care systems.

authors

  • Aby, Elizabeth S
  • Moafa, Ghady
  • Latt, Nyan
  • Sultan, Mohammad T
  • Cacioppo, Paula A
  • Kumar, Sonal
  • Chung, Raymond T
  • Bloom, Patricia P
  • Gustafson, Jenna
  • Daidone, Michael
  • Reinus, Zoe
  • Debes, Jose D
  • Sandhu, Sunny
  • Sohal, Aalam
  • Khalid, Sameeha
  • Roytman, Marina
  • Catana, Andreea Maria
  • Wegermann, Kara
  • Carr, Rotonya M
  • Saiman, Yedidya
  • Kassab, Ihab
  • Chen, Vincent L
  • Rabiee, Atoosa
  • Rosenberg, Carly
  • Nguyen, Veronica
  • Gainey, Christina
  • Zhou, Kali
  • Chavin, Kenneth
  • Lizaola-Mayo, Blanca C
  • Chascsa, David M
  • Varelas, Lee
  • Moghe, Akshata
  • Dhanasekaran, Renumathy

publication date

  • January 3, 2023

Research

keywords

  • COVID-19
  • Liver Diseases

Identity

PubMed Central ID

  • PMC9827967

Scopus Document Identifier

  • 85149290014

Digital Object Identifier (DOI)

  • 10.3389/fmed.2021.778434

PubMed ID

  • 36633476

Additional Document Info

volume

  • 7

issue

  • 1